SCHEMBL634042

SCHEMBL634042

CCCCCCCCC(CCCCCCCCCN1C(=O)C=CC1=O)C(CCCCCCCC)CCCCCCCCCN1C(=O)C=CC1=O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 8/20 0.79
PTGS1 P23219 7/20 0.79
PTGS2 P35354 7/20 0.79
FAAH O00519 5/20 0.79
ALDH1A1 P00352 3/20 0.61
LMNA P02545 2/20 0.61
MAPT P10636 2/20 0.61
NPSR1 Q6W5P4 2/20 0.61
HSP90AA1 P07900 1/20 0.61
TLR9 Q9NR96 1/20 0.61
TP53 P04637 1/20 0.61
PKM P14618 1/20 0.61
HPGD P15428 1/20 0.61
XBP1 P17861 1/20 0.61
MAPK1 P28482 1/20 0.61
HTT P42858 1/20 0.61
RECQL P46063 1/20 0.61
RAB9A P51151 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
GPR35 Q9HC97 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15854884 1.00 MGLL (0.79) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL15853885 1.00 MGLL (0.79) MGLLPTGS1PTGS2FAAHALDH1A1
Ammonia Solution, Strong SCHEMBL4469556 0.98 MGLL (0.76) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL21610374 0.91 MGLL (0.65) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL9640374 0.89 MGLL (1.00) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL36400 0.89 MGLL (1.00) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL2181536 0.89 MGLL (1.00) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL209436 0.89 MGLL (1.00) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL9497658 0.89 MGLL (1.00) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL65639 0.89 MGLL (1.00) MGLLPTGS1PTGS2FAAHALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7102015-B2 Maleimide compounds in liquid form HENKEL CORPORATION (US) 2006-09-05 US claimed
US-20050136620-A1 Maleimide compounds in liquid form HENKEL CORPORATION 2005-06-23 US claimed
US-6825245-B2 SOLVENT-FREE; CONTROLLING VISCOSITY; MATERIAL HANDLING HENKEL CORPORATION 2004-11-30 US claimed
US-20250382514-A1 CURABLE ADHESIVE COMPOSITION COMPRISING MALEIMIDE AND THIOL HENKEL AG & CO KGAA (DE) 2025-12-18 US disclosed
CN-118266072-A Liquid molding compounds, and reaction products thereof that become electroplatable when exposed to laser energy 汉高股份有限及两合公司 2024-06-28 CN disclosed
EP-4301823-A1 CURABLE ADHESIVE COMPOSITION COMPRISING MALEIMIDE AND THIOL Henkel AG & Co. KGaA (DE) 2024-01-10 EP disclosed
CN-116940647-A Curable adhesive composition comprising maleimide and thiol 汉高股份有限及两合公司 2023-10-24 CN disclosed
WO-2023091578-A1 LIQUID MOLD COMPOUNDS, REACTION PRODUCTS OF WHICH BECOME PLATABLE UPON EXPOSURE TO LASER ENERGY HENKEL AG & CO. KGAA (DE) 2023-05-25 WO disclosed
US-20230114308-A1 Flux-Compatible Epoxy-Anhydride Adhesives Compositions for Low-Gap Underfill Applications HENKEL AG & CO KGAA (DE) 2023-04-13 US disclosed
CN-115715313-A Flux compatible epoxy-anhydride adhesive compositions for low gap underfill applications 汉高股份有限及两合公司 2023-02-24 CN disclosed
US-11578202-B2 Liquid compression molding encapsulants HENKEL AG & CO. KGAA (DE) 2023-02-14 US disclosed
US-6211320-B1 CYCLOPENTADIENE OLIGOMER DEXTER CORPORATION 2001-04-03 US disclosed
WO-2001009078-A1 LOW VISCOSITY ACRYLATE MONOMERS, FORMULATIONS CONTAINING SAME, AND USES THEREFOR DEXTER CORPORATION (US) 2001-02-08 WO disclosed
US-6034194-A BLEND CONTAINING UNSATURATED COMPOUND AND PEROXIDE FREE RADICAL CATALYST QUANTUM MATERIALS/DEXTER CORPORATION (US) 2000-03-07 US disclosed
US-6034195-A BLEND CONTAINING UNSATURATED COMPOUND AND PEROXIDE FREE RADICAL CATALYST DEXTER CORPORATION (US) 2000-03-07 US disclosed
EP-0915919-A1 PERFLUORINATED HYDROCARBON POLYMER-FILLED ADHESIVE FORMULATIONS AND USES THEREFOR QUANTUM MATERIALS, INC. (US) 1999-05-19 EP disclosed
US-5717034-A Perfluorinated hydrocarbon polymer-filled adhesive formulations and uses therefor QUANTUM MATERIALS, INC. (US) 1998-02-10 US disclosed
WO-1998004602-A1 PERFLUORINATED HYDROCARBON POLYMER-FILLED ADHESIVE FORMULATIONS AND USES THEREFOR QUANTUM MATERIALS, INC. (US) 1998-02-05 WO disclosed
EP-0778857-A2 THERMOSETTING RESIN COMPOSITIONS CONTAINING MALEIMIDE AND/OR VINYL COMPOUNDS QUANTUM MATERIALS, INC. (US) 1997-06-18 EP disclosed
WO-1996007691-A2 THERMOSETTING RESIN COMPOSITIONS CONTAINING MALEIMIDE AND/OR VINYL COMPOUNDS QUANTUM MATERIALS, INC. (US) 1996-03-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050136620-A1 Maleimide compounds in liquid form MLEC, MSMO1, ICAM1 MGLL 2877/4885PTGS1 1011/4885PTGS2 996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.